Loading...
OTCM
SYBX
Market cap14mUSD
Sep 11, Last price  
1.22USD
1D
0.00%
1Q
64.86%
Jan 2017
-99.35%
IPO
-99.84%
Name

Synlogic Inc

Chart & performance

D1W1MN
OTCM:SYBX chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
38.81%
Rev. gr., 5y
-67.55%
Revenues
0
-100.00%
00000444,0002,444,0002,520,0002,224,000545,0001,754,0001,180,0003,371,0008,0000
Net income
-1m
L-95.70%
-2,883,000-3,658,000-6,436,000-15,834,000-24,983,000-26,268,000-40,377,000-48,435,000-51,373,000-59,173,000-60,561,000-66,147,000-57,282,000-23,359,000-1,005,000
CFO
-4m
L-86.23%
-4,520,000-6,496,000-13,970,000-21,135,000-24,805,000-31,055,000-42,470,000-75,468,000-39,553,000-52,198,000-56,888,000-51,614,000-31,658,000-4,359,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

Key people

Aoife M. Brennan
President, Chief Executive Officer, Director · since 2018
Gregg D. Beloff
Chief Financial Officer, Principal Accounting Officer · since 2019
Michael Slater
Head of Regulatory Affairs · since 2019
Patricia N. Hurter
Independent Director · since 2019
Chau Q. Khuong
Independent Director · since 2017
Nick Leschly
Independent Director · since 2017
Edward T. Mathers
Independent Director · since 2012
Richard P. Shea
Independent Director · since 2017
URL
https://www.synlogictx.com/
IPO date
Sep 30, 2015
Employees
72
Domiciled in
US
Incorporated in
US
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
Wilmington, DE 19808
US
Headquarters
2150 Woodward Street
Suite 100
Austin, TX 78744
US
Previous name
Mirna Therapeutics, Inc.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT